The objective of this webinar was to provide an overview of the available front-line therapeutic options for patients with metastatic pancreatic cancer and compare the relative effectiveness and potential side effect profiles of different chemotherapeutic regimens.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content